Syndax Pharmaceuticals Inc.

SNDX | NASDAQ

Price Alert Chart Builder DCF Calculator

$18.03

-$0.04 (-0.22%)

Sep 22, 2026, 12:06 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-285.42M	-318.76M	-209.36M	-149.34M	24.93M	-73.16M
Depreciation & Amortization	6K	8K	12K	33K	43K	89K
Stock-Based Compensation	47.5M	43.03M	30.95M	16.02M	13.32M	9.06M
Other Working Capital	-15.35M	23.21M	15.54M	2.98M	-11.76M	-5.26M
Other Non-Cash Items	-5.75M	-12.45M	-14.06M	-2.05M	187K	686K
Deferred Income Tax	n/a	n/a	n/a	n/a	255K	n/a
Change in Working Capital	-79.32M	13.27M	31.86M	1.66M	-9.6M	-7.93M
Operating Cash Flow	-322.98M	-274.9M	-160.6M	-133.68M	29.13M	-71.26M
Capital Expenditures	-187K	n/a	n/a	-225K	-129K	n/a
Cash Acquisitions	n/a	n/a	n/a	225K	40.74K	n/a
Purchase of Investments	-195.81M	-557.05M	-354.61M	-495.35M	-294.72M	-278.94M
Sales Maturities Of Investments	486.03M	337.28M	472.22M	308.93M	253.98M	136.41M
Other Investing Acitivies	n/a	n/a	n/a	225K	-40.74K	n/a
Investing Cash Flow	290.04M	-219.78M	117.61M	-186.19M	-40.87M	-142.53M
Debt Repayment	n/a	n/a	n/a	-21M	n/a	19.73M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	343.65M	6.04M	11.86M	32.13M	6.63M
Financial Cash Flow	13.68M	353.37M	264.13M	172.25M	118.46M	304.42M
Net Cash Flow	-19.27M	-141.31M	221.14M	-147.61M	106.72M	90.63M
Free Cash Flow	-323.17M	-274.9M	-160.6M	-133.9M	29M	-71.26M
Adj. Free Cash Flow	-370.67M	-317.93M	-191.55M	-149.92M	15.69M	-80.32M
Maintenance CapEx	n/a	n/a	n/a	-225K	n/a	n/a
Growth CapEx	-187K	n/a	n/a	n/a	-129K	n/a
Owner Earnings	-322.98M	-274.9M	-160.6M	-133.9M	29.13M	-71.26M